MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • MDS Virtual Congress 2021

    BASELINE OLFACTION TESTING IN PARKINSON’S DISEASE PATIENTS IS CORRELATED WITH LONG-TERM DOPAMINERGIC DENERVATION IN STRIATAL SUB-REGIONS: LONGITUDINAL DATA FROM THE PPMI STUDY.

    C. Koros, A-M. Simitsi, N. Papagiannakis, A. Prentakis, A. Bougea, D. Papadimitriou, R. Antonelou, I. Pachi, E. Angelopoulou, E. Stanitsa, I. Beratis, S. Papageorgiou, M. Stamelou, X. Trapali, L. Stefanis (Athens, Greece)

    Objective: The aim of the current study was to determine whether there are longitudinal differences in dopaminergic denervation of striatal sub-regions [signal reduction in 123I-FP-CIT…
  • MDS Virtual Congress 2021

    Relationship Between Hyposmia and Olfactory Network Connectivity in Patients With Parkinson’s Disease

    L. Pesantez Pacheco, S. Horovitz (Bethesda, USA)

    Objective: To examine resting-state functional Magnetic Resonance Imaging in a group of Parkinson’s Disease patients, used to characterize changes in functional connectivity of the olfactory…
  • MDS Virtual Congress 2021

    Predictive value of UPSIT subsets in prodromal Parkinson disease

    P. Vaswani, J. Morley, D. Jennings, A. Siderowf, K. Marek, P. Investigators (Philadelphia, USA)

    Objective: To assess the predictive value of previously published subsets of the University of Pennsylvania Smell Identification Test (UPSIT) odors for conversion to Parkinson disease…
  • MDS Virtual Congress 2021

    Serial olfactory testing for the diagnosis of prodromal Parkinson disease in the Parkinson Associated Risk Syndrome (PARS) study

    P. Vaswani, J. Morley, D. Jennings, A. Siderowf, K. Marek, P. Investigators (Philadelpiha, USA)

    Objective: To assess whether repeat olfactory testing in initially hyposmic subjects improves prediction of conversion to Parkinson disease (PD). Background: Hyposmia is a common prodromal…
  • MDS Virtual Congress 2021

    Smell dysfunction correlates with severity of motor deficits in H&Y stage-I early onset Parkinson’s disease

    J. Wang, R. Stanford, Q. Yang, L. Spreen, M. Wang, B. Mullen, K. Venkiteswaran, T. Subramanian (Hershey, USA)

    Objective: The objective of this study is to test the hypotheses that: 1) olfactory dysfunction in early stage Parkinson’s disease (PD) is correlated with severity…
  • MDS Virtual Congress 2020

    Improving estimation of Parkinson’s disease risk – enhancing the PREDICT-PD algorithm

    J. Bestwick, S. Auger, D. Grosset, S. Kanavou, G. Giovannoni, A. Lees, J. Cuzick, C. Simonet, R. Rees, D. Rack, M. Jitlal, A. Schrag, A. Noyce (London, United Kingdom)

    Objective: To develop and test an enhanced algorithm for the prediction of Parkinson’s disease (PD) risk. Background: The PREDICT-PD algorithm estimates risk of PD using…
  • MDS Virtual Congress 2020

    Hyposmia as a biomarker in patients with Parkinson’s disease and atypical Parkinsonism

    S. Kumaran, A. Ankeeta, S. Chaudhary, P. Bhat, V. Goyal (New Delhi, India)

    Objective: To investigate neural correlates associated with olfactory dysfunction using fMRI and EEG in Parkinsonism. Background: Patients with Parkinsonism experience non-motor symptoms during the onset…
  • MDS Virtual Congress 2020

    The role of dopamine mis-metabolism in preclinical Parkinson’s disease olfactory deficits

    L. Beauchamp, L. Vella, A. Bush, K. Barnham (Melbourne, Australia)

    Objective: To gain an understanding of the underlying pathological mechanisms of Parkinson’s disease (PD)-related hyposmia using post-mortem human olfactory bulbs and an in vivo model…
  • MDS Virtual Congress 2020

    Difference in olfactory impairment between tremor dominant and akinetic rigid dominant Parkinson’s disease patients

    P. Solla, C. Masala, P. Raffaella, S. Dagostino, T. Ercoli, G. Defazio (Monserrato, Italy)

    Objective: To investigate difference in olfactory impairment between tremor dominant (TD) and akinetic rigid dominant (ARD) Parkinson’s disease patients. Background: PD can be classified in…
  • MDS Virtual Congress 2020

    Diagnostic value of olfactory dysfunction in Parkinson’s disease

    K. Stepanchenko, V. Marchenko, A. Zhidkova (Kharkiv, Ukraine)

    Objective: To assess the olfactory performance in patients with PD using “Sniffin’ Sticks”. Background: Olfactory dysfunction is an important early premotor biomarker for PD, and…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 15
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley